What is it about?
Based on current clinical evidences, we discuss the appropriate management of patent foramen ovale
Featured Image
Why is it important?
The patent foramen ovale (PFO) is a very common anomaly. His role in cryptogenic stroke has been emphasized over the last 20 years. The lack of definitive guidelines has led to very heterogeneous behaviors, sometimes with indiscriminate percutaneous closure. PFO should not be treated in primary prevention, percutaneous closure should not be the first line treatment. This review discuss current knowledge derived from clinical studies and provide practical clinical guidelines for the daily management of patients with PFO.
Perspectives
At the end of this review are listed and discussed practical key points. We think that “key points” can be useful in daily clinical practice, not just for cardiologists, but also for neurologists, ophthalmologists, internal medicine physicians, sport physicians, and all medical doctors who must manage PFO patients.
Ketty Savino
Read the Original
This page is a summary of: Patent foramen ovale and cryptogenic stroke: from studies to clinical practice, International Journal of Clinical Practice, July 2016, Wiley,
DOI: 10.1111/ijcp.12842.
You can read the full text:
Contributors
The following have contributed to this page
